Status Covid-19/Flu A&B
Princeton BioMeditech Corporation
A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen from anterior nasal and nasopharyngeal swab specimens.
- Covid-19: Anterior nasal swab specimen − Sensitivity 93.8 %, Specificity 100%
- Covid-19: Nasopharyngeal − Sensitivity 93.1 %, Specificity 100%
- Flu A: Sensitivity 91.4%, Specificity 95.7%
- Flu B: Sensitivity 87.6%, Specificity 95.9%
- FDA Emergency Use Authorization (EUA)
- Visually read in 15 minutes
- Flocked nasopharyngeal swab for superior specimen collection and patient comfort
